Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Anti-CD20 monoclonal antibodies
1 evidence topic · 1 source
Tirabrutinib
Primary central nervous system lymphoma
- Manufacturer
- Deciphera Pharmaceuticals
- Regulatory submission
- NDA submitted December 2025
- Last updated